XML 37 R23.htm IDEA: XBRL DOCUMENT
v3.25.0.1

EARNINGS PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2024
Earnings Per Share [Abstract] |
EARNINGS PER SHARE | EARNINGS PER SHARE The following table details the reconciliation of basic earnings per share to diluted earnings per share:
| Years Ended December 31,
| 2024 |  | 2023 |  | 2022
Numerator for basic and diluted earnings per share: |  |  |  |  |
Net income | $ | 263,026 |  |  | $ | 165,919 |  |  | $ | 164,240 |
Denominator: |  |  |  |  |
Weighted-average basic common shares outstanding | 42,611 |  |  | 42,024 |  |  | 41,544 |
Assumed conversion of dilutive securities: |  |  |  |  |
Stock awards | 793 |  |  | 745 |  |  | 855 |
Convertible Senior Notes | 93 |  |  | — |  |  | — |
Denominator for diluted earnings per share - Adjusted weighted-average shares | 43,497 |  |  | 42,769 |  |  | 42,399 |
Earnings per common share: |  |  |  |  |
Basic | $ | 6.17 |  |  | $ | 3.95 |  |  | $ | 3.95 |
Diluted | $ | 6.05 |  |  | $ | 3.88 |  |  | $ | 3.87 |
Stock awards representing the right to purchase common stock of approximately 67,000 shares in 2024, 343,000 shares in 2023, and 372,000 shares in 2022, were not included in the computation of diluted earnings per share because their inclusion would have had an antidilutive effect. We have used the if-converted method for calculating any potential dilutive effect of the Convertible Senior Notes on our diluted net income per share if our average stock price for the period exceeded the conversion price of $493.44 per share of common stock. Under the if-converted method, the Notes are assumed to be converted at the beginning of the period and the resulting common shares, if dilutive, are included in the denominator of the diluted earnings per share calculation for the entire period being presented. For the twelve months ended December 31, 2024, our average stock price for the period exceeded the conversion price resulting in a dilutive impact of the if-converted method as reflected in the table above. For the twelve months ended December 31, 2023 and 2022, our average stock price for the period did not exceed the conversion price, therefore there was no dilutive impact as reflected in the table above.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration